Lonza operates one of the largest Western contract development and manufacturing organizations (CDMO) for pharmaceuticals and biologics, with ~18,500 employees across five continents. The tech stack reflects a manufacturing-heavy operation: SAP dominates finance and materials management (MM, CO/FI, BW), while MES and LIMS handle production and lab workflows. Active adoption of SAP S/4HANA, EWM, Azure, and Benchling signals a multi-year shift toward modern cloud and biotech-specific tooling — a strategic move for a 127-year-old company modernizing legacy manufacturing systems. Hiring velocity is accelerating across manufacturing (346 open roles), engineering (184), and operations, with particular focus on capital projects, process validation, and regulatory compliance automation.
Notable leadership hires: Head of EHS, Quality Director, Process Validation Lead, Manufacturing Lead, Logistics Team Lead
Lonza manufactures active pharmaceutical ingredients, biopharmaceutical drug substances and finished dosage forms, and life science ingredients for customers across the pharma, biotech, nutrition, and cell/gene therapy sectors. The company operates manufacturing sites in Switzerland, the United States, India, the United Kingdom, China, and other key markets, serving as a contract partner for customers bringing breakthrough therapies to market. Core operational priorities center on GMP and cGMP compliance, plant availability, process validation, continuous improvement, and technology transfer of customer manufacturing processes. The business combines traditional chemical manufacturing (SAP MM, CNC, 3D printing) with advanced biopharmaceutical production (Benchling, Biacore), reflecting the dual nature of CDMO work across small molecules and biologics.
Manufacturing and business systems: SAP (MM, CO/FI, BW, S/4HANA migration), MES, LIMS, Salesforce. Engineering and biotech tools: Benchling, CAD, Navisworks, AWS EMR, Azure adoption. Data/analytics: SQL Server, Python, Power BI. Adopting: Azure, SAP EWM, LIMS modernization.
Capital investment and technology transfer projects for customer manufacturing processes, process validation, automation system development, cGMP compliance and quality automation, continuous improvement via Lean Six Sigma and CAPA implementation, and digital platform modernization for global pharmaceutical operations.
Other companies in the same industry, closest in size